跳至主要内容
临床试验/JPRN-UMIN000012175
JPRN-UMIN000012175已完成2 期

Phase II trial of Cisplatin and Irinotecan treatment as palliative-intended chemotherapy for previously untreated advanced thymic carcinoma - CDDP/CPT-11 for advanced thymic carcinoma

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital0 个研究点目标入组 0 人开始时间: 2013年11月30日最近更新:
适应症

试验速览

研究概览

简要总结

o patient was enrolled.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. With concurrent active cancer 2. Serious uncontrolled infections 3. With fever at more than 38 degree in Celicius 4. Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 5. 6. 7. With malignant pleural, peritoneal effusion requiring drainage or pericardial effusion 6. With sever complication associated with operation 7. Under continuous steroid therapy 8. With uncontrolled diabetes melitus 9. With uncontrolled hypertension 10 Unstable angina or previous history of myocardial infarction within six months 11. With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray

研究者

相似试验